60 related articles for article (PubMed ID: 8500578)
1. Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review.
Lynch OF; Calvi LM
Cells; 2022 Feb; 11(3):. PubMed ID: 35159389
[TBL] [Abstract][Full Text] [Related]
2. The role of ras and other low molecular weight guanine nucleotide (GTP)-binding proteins during hematopoietic cell differentiation.
Scheele JS; Ripple D; Lübbert M
Cell Mol Life Sci; 2000 Dec; 57(13-14):1950-63. PubMed ID: 11215520
[TBL] [Abstract][Full Text] [Related]
3. Experimental model for MDS-like myelodysplasia in transgenic mice harboring the SV40 large-T antigen under an immunoglobulin enhancer.
Inoue T; Hirabayashi Y; Mitsui H; Furuta Y; Suda Y; Aizawa S; Ikawa Y
Leukemia; 1994 Apr; 8 Suppl 1():S202-5. PubMed ID: 8152293
[TBL] [Abstract][Full Text] [Related]
4. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
5. Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen.
Hough MR; Chappel MS; Sauvageau G; Takei F; Kay R; Humphries RK
J Immunol; 1996 Jan; 156(2):479-88. PubMed ID: 8543797
[TBL] [Abstract][Full Text] [Related]
6. AlphaIIb integrin expression during development of the murine hemopoietic system.
Corbel C; Salaün J
Dev Biol; 2002 Mar; 243(2):301-11. PubMed ID: 11884039
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic transforming potential of activated ras in chimeric mice.
Hawley RG; Fong AZ; Ngan BY; Hawley TS
Oncogene; 1995 Sep; 11(6):1113-23. PubMed ID: 7566971
[TBL] [Abstract][Full Text] [Related]
8. MDS-like experimental myelodysplasia: multilineage abnormal hematopoiesis in transgenic mice harboring the SV40 large T antigen under an immunoglobulin enhancer.
Furuta Y; Aizawa S; Suda Y; Ikawa Y; Nishikawa S; Hayashi S; Hirabayashi Y; Inoue T
Exp Hematol; 1993 Jun; 21(6):806-15. PubMed ID: 8500578
[TBL] [Abstract][Full Text] [Related]
9. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
Preisler HD
Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
[No Abstract] [Full Text] [Related]
10. Innate immune signaling in the myelodysplastic syndromes.
Starczynowski DT; Karsan A
Hematol Oncol Clin North Am; 2010 Apr; 24(2):343-59. PubMed ID: 20359630
[TBL] [Abstract][Full Text] [Related]
11. Lymphocytes, lymphokines, and hematopoiesis.
Garland JM
Immunol Ser; 1990; 49():297-328. PubMed ID: 2090255
[TBL] [Abstract][Full Text] [Related]
12. In vitro hematopoiesis in myelodysplasia: liquid and soft-gel culture studies.
Richert-Boe KE; Bagby GC
Hematol Oncol Clin North Am; 1992 Jun; 6(3):543-56. PubMed ID: 1613005
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
